» Articles » PMID: 16455885

Use of an Adaptation of a Commercially Available PCR Assay Aimed at Diagnosis of Chlamydia and Gonorrhea to Detect Trichomonas Vaginalis in Urogenital Specimens

Overview
Specialty Microbiology
Date 2006 Feb 4
PMID 16455885
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Trichomonas vaginalis PCR using reagents from a commercially available assay for Chlamydia trachomatis and Neisseria gonorrhoeae was evaluated for detection of infection in women and men attending a sexually transmitted disease clinic. Evaluations included three primer sets, endocervical swabs, vaginal swabs and urine, and various storage conditions. The TVK3/TVK7 primer set was optimal in our hands with sensitivities ranging from 69.5 to 96.8%. In all comparisons, T. vaginalis PCR performed better than routine diagnostics using microscopy for women and culture for men (P > 0.05). The assay performed well for all sample types tested, and vaginal swabs were stable for up to 7 days at ambient temperature. Using samples prepared for, and reagents from, the C. trachomatis-N. gonorrhoeae PCR assay allowed incorporation of T. vaginalis PCR diagnosis into routine clinical testing.

Citing Articles

Epidemiology, Natural History, Diagnosis, and Treatment of Trichomonas vaginalis in Men.

Van Gerwen O, Camino A, Sharma J, Kissinger P, Muzny C Clin Infect Dis. 2021; 73(6):1119-1124.

PMID: 34079999 PMC: 8522801. DOI: 10.1093/cid/ciab514.


Management of Resistant Trichomoniasis.

Alessio C, Nyirjesy P Curr Infect Dis Rep. 2019; 21(9):31.

PMID: 31388764 DOI: 10.1007/s11908-019-0687-4.


Review of in Iran, Based on Epidemiological Situation.

Arbabi M, Delavari M, Fakhrieh-Kashan Z, Hooshyar H J Reprod Infertil. 2018; 19(2):82-88.

PMID: 30009141 PMC: 6010820.


Genotype-Specific Concordance of Chlamydia trachomatis Genital Infection Within Heterosexual Partnerships.

Schillinger J, Katz B, Markowitz L, Braslins P, Shrier L, Madico G Sex Transm Dis. 2016; 43(12):741-749.

PMID: 27835626 PMC: 5113142. DOI: 10.1097/OLQ.0000000000000525.


A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.

Meites E, Gaydos C, Hobbs M, Kissinger P, Nyirjesy P, Schwebke J Clin Infect Dis. 2015; 61 Suppl 8:S837-48.

PMID: 26602621 PMC: 4657597. DOI: 10.1093/cid/civ738.


References
1.
Moodley P, Wilkinson D, Connolly C, Moodley J, Sturm A . Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis. 2002; 34(4):519-22. DOI: 10.1086/338399. View

2.
Buve A, Weiss H, Laga M, Van Dyck E, Musonda R, Zekeng L . The epidemiology of trichomoniasis in women in four African cities. AIDS. 2001; 15 Suppl 4:S89-96. DOI: 10.1097/00002030-200108004-00010. View

3.
Kaydos S, Swygard H, Wise S, Sena A, Leone P, Miller W . Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Microbiol. 2002; 40(1):89-95. PMC: 120133. DOI: 10.1128/JCM.40.1.89-95.2002. View

4.
Gram I, Macaluso M, Churchill J, Stalsberg H . Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III. Cancer Causes Control. 1992; 3(3):231-6. DOI: 10.1007/BF00124256. View

5.
Schwebke J, Hook 3rd E . High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis. 2003; 188(3):465-8. DOI: 10.1086/376558. View